Interleukin-2 is a potent latency reversal agent in people with treated HIV-1

Journal:

Science Advances

Published:

2025-12-19

DOI:

10.1126/sciadv.aea4268

Affiliations:

5

Authors:

11

Go to article

Institutions	Authors	Share
University Hospitals Cleveland Medical Center, CWRU, United States of America (USA)	5.333333	0.48
Case Western Reserve University (CWRU), United States of America (USA)	4.666667	0.42
Accelevir Diagnostics, United States of America (USA)	1.000000	0.09

Interested in Clinical Sciences?